Cite
Correlation of HLA-B*35 and DRB1*11 alleles with a high risk of interstitial aseptic pneumonitis in cancer patients receiving PD-1/PDL1 immune-checkpoint blockade
MLA
Eleonora Iuliano, et al. “Correlation of HLA-B*35 and DRB1*11 Alleles with a High Risk of Interstitial Aseptic Pneumonitis in Cancer Patients Receiving PD-1/PDL1 Immune-Checkpoint Blockade.” Journal of Clinical Oncology, vol. 38, May 2020, p. e15094. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........158950d7652285895704d36e3f1f82c9&authtype=sso&custid=ns315887.
APA
Eleonora Iuliano, Andrea Sergi, Pierpaolo Correale, Giovanna Bianco, Amalia Luce, Alessia Stranges, Maria Antonietta Mazzei, Rita Emilena Saladino, Pierpaolo Pastina, Pierfrancesco Tassone, M. Altomonte, Rocco Giannicola, Paolo Tini, Natale Daniele Calandruccio, Pierosandro Tagliaferri, Michele Caraglia, Daniele Caracciolo, Luigi Pirtoli, Valerio Nardone, & Diana Giannarelli. (2020). Correlation of HLA-B*35 and DRB1*11 alleles with a high risk of interstitial aseptic pneumonitis in cancer patients receiving PD-1/PDL1 immune-checkpoint blockade. Journal of Clinical Oncology, 38, e15094.
Chicago
Eleonora Iuliano, Andrea Sergi, Pierpaolo Correale, Giovanna Bianco, Amalia Luce, Alessia Stranges, Maria Antonietta Mazzei, et al. 2020. “Correlation of HLA-B*35 and DRB1*11 Alleles with a High Risk of Interstitial Aseptic Pneumonitis in Cancer Patients Receiving PD-1/PDL1 Immune-Checkpoint Blockade.” Journal of Clinical Oncology 38 (May): e15094. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........158950d7652285895704d36e3f1f82c9&authtype=sso&custid=ns315887.